These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25177087)
1. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Saad WE Semin Intervent Radiol; 2014 Sep; 31(3):258-61. PubMed ID: 25177087 [TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension]. Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906 [No Abstract] [Full Text] [Related]
10. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261 [TBL] [Abstract][Full Text] [Related]
11. Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation. Saad WE Semin Intervent Radiol; 2014 Sep; 31(3):243-7. PubMed ID: 25177084 [TBL] [Abstract][Full Text] [Related]
12. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Colombato L J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717 [TBL] [Abstract][Full Text] [Related]
15. [Effect of covered stent length in portal and hepatic veins on long-term clinical efficacy of transjugular intrahepatic portosystemic shunt]. Hu P; Chen SL; Lin ZP; Zhao JB; Chen Y; He XF; Zeng QL; Li YH Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1444-1448. PubMed ID: 27777214 [TBL] [Abstract][Full Text] [Related]
16. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study. Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935 [TBL] [Abstract][Full Text] [Related]
17. Portosystemic Shunts: Stable Utilization and Improved Outcomes, Two Decades After the Transjugular Intrahepatic Portosystemic Shunt. Perry BC; Kwan SW J Am Coll Radiol; 2015 Dec; 12(12 Pt B):1427-33. PubMed ID: 26410348 [TBL] [Abstract][Full Text] [Related]
18. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Riggio O; Ridola L; Lucidi C; Angeloni S Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625 [TBL] [Abstract][Full Text] [Related]
19. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. Yang Z; Han G; Wu Q; Ye X; Jin Z; Yin Z; Qi X; Bai M; Wu K; Fan D J Gastroenterol Hepatol; 2010 Nov; 25(11):1718-25. PubMed ID: 21039832 [TBL] [Abstract][Full Text] [Related]